NanoVibronix, a leading medical device company specializing in ultrasonic therapeutic devices, has recently announced that its PainShield product will be included in the U.S. Department of Veteran Affairs (VA) Federal Supply Schedule (FSS) starting May 1, 2024. This significant milestone allows the Company to support the healthcare acquisition needs of the VA, further positioning itself as a provider of innovative solutions for pain management. In a letter to shareholders, NanoVibronix’s Chief Executive Officer, Brian Murphy, provided an overview of the third quarter of 2023 and highlighted recent business developments.
NanoVibronix’s PainShield product, a Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Device, has been granted inclusion in the VA’s FSS program. The FSS program facilitates the acquisition of healthcare products for the VA, highlighting the increasing recognition and demand for NanoVibronix’s pain management technology.
With this development, NanoVibronix can now cater to the healthcare needs of veterans across the United States more effectively. The inclusion of PainShield in the FSS will enable veterans to access the innovative pain management solution, expanding their options for non-invasive and drug-free relief.
NanoVibronix’s commitment to its strategic vision of developing and commercializing advanced medical devices is evident through its consistent efforts to improve and enhance its product line. The company’s dedication to providing effective therapeutic options such as UroShield, PainShield, and WoundShield demonstrates its commitment to delivering cutting-edge solutions in the field of ultrasound technology.
In a letter to shareholders, CEO Brian Murphy emphasized the company’s commitment to its strategic goals and highlighted the positive business developments of the third quarter of 2023. The letter serves as an assurance to shareholders regarding the company’s progress, which is backed by the inclusion of PainShield in the VA’s FSS program.
Conclusion:NanoVibronix’s PainShield being included in the U.S. Department of Veteran Affairs (VA) Federal Supply Schedule (FSS) is a significant achievement that enhances the company’s position as a trusted provider of advanced medical devices. This milestone not only expands access to innovative pain management solutions for veterans but also reinforces NanoVibronix’s commitment to developing and commercializing cutting-edge therapeutic devices. With this inclusion, NanoVibronix is poised for further growth and success in the healthcare industry.
Comments